nuc-7738
Generic: Fosdesdenosine Sipalabenamide
nuc-7738: 1 clinical trial tracked.
nuc-7738 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about nuc-7738, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase I/II, Open-label, Dose-escalation and Expansion Study to Assess the Safety, Pharmacokinetics and Clinical Activity of NUC-7738, a Nucleotide Analogue, in Patients With Advanced Solid Tumours and Lymphoma
Primary endpoint: Number of patients with dose-limiting toxicities
Interventionalopen135 targetStarted 2019-06Completion 2026-089 sites · United KingdomNuCana plc